High Prevalence of Anemia Among Human Immunodeficiency Virus-Infected Patients Treated with Antiretroviral Therapy
Sri Agung Aryastuti (a*), Sri Ratna Dewi (a), Putu Nita Cahyawati (a), Dewa Gede Budiyasa (b), Ketut Suryana (c), Sri Masyeni (a)
a)Faculty of Medicine and Health Science, Warmadewa University, Jl. Terompong No. 24 Denpasar, Bali-Indonesia
sriagungary[at]gmail.com
b)Sanjiwani Hospital, Jl. Ciung Wanara No. 2 Gianyar, Bali-Indonesia
c)Wangaya Hospital, Jl. Kartini No. 133 Denpasar, Bali-Indonesia
Abstract
Anemia is a common condition found among Human Immunodeficiency Virus (HIV)-infected patients. T-cells that are infected with HIV virus can directly suppress the growth of progenitor cells in the bone marrow so that affecting the hemopoiesis resulted in anemia. These hematological abnormalities could potentially cause serious clinical implications. This study was conducted to determine the prevalence of anemia in HIV-infected patients in Bali. A total of 243 medical record data from HIV-infected patients at Wangaya Hospital Denpasar Bali and Sanjiwani Hospital Gianyar Bali between 2009 -2017 were included in analysis. Prevalence of anemia in ART-naïve patients and in patients on ART were 60.8% and 40.3%, respectively. Leucopenia and thrombocytopenia were found 8.2% and 9.4%, respectively, in ART-naïve group. While in patients with ART group leucopenia and thrombocytopenia were accounted for 6.9% and 4.3%, respectively. There was a significant difference in prevalence of anemia between ART-naïve patients and patients on ART (60.8% vs 40.3%; p < 0.05). Although the prevalence of anemia was lower in patients on ART, but anemia continues to be common in a substantial portion of HIV-infected persons. Another studies are still needed to addressing the impact of anemia on HIV-infected individuals, as well as treatment strategies and future research directions.
Keywords: anemia, HIV, antiretroviral therapy
Topic: Pharmacology